Surgical Management of Epistaxis in Hereditary Hemorrhagic Telangiectasia
- 1 July 1987
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 113 (7) , 754-757
- https://doi.org/10.1001/archotol.1987.01860070068018
Abstract
• The most common manifestation of hereditary hemorrhagic telangiectasia (HH) is recurrent epistaxis. Numerous treatments have been used over the years, none proving entirely satisfactory. We have applied a new surgical treatment in seven selected cases of HHT with severe, life-threatening epistaxis. It consists of a near-total excision of the diseased nasal mucosa and its replacement by different skin flaps or a myocutaneous flap. This procedure has been performed since 1981. We stress the reliability and versatility of using the forehead myocutaneous island flap. Our original technique is described, follow-up of the patients is reported, and the criteria for selection of treatment are discussed. (Arch Otolaryngol Head Neck Surg 1987;113:754-757)This publication has 4 references indexed in Scilit:
- The management of severe recurrent epistaxis due to Hereditary Hemorrhagic Telangiectasia using regional facial cutaneous flapsThe Journal of Laryngology & Otology, 1985
- Amniotic graft in the management of severe epistaxis due to hereditary haemorrhagic telangiectasiaThe Journal of Laryngology & Otology, 1979
- Effect of Amniotic Fluid on Blood CoagulationBritish Journal of Haematology, 1972
- FAMILIAL HAEMORRHAGIC TELANGIECTASIA120 Cases treated with Systemic OestrogenQJM: An International Journal of Medicine, 1964